## 3 Results
### Antimicrobial and Antifungal Activity
\begin{table}
\begin{tabular}{l c c c c c c} \hline \hline \multirow{2}{*}{**Types of Microorganisms**} & \multirow{2}{*}{**Clinical Material**} & \multirow{2}{*}{**Resistance**} & \multicolumn{4}{c}{**Diameters of Growth Inhibition Zones, mm**} \\  & & & \multicolumn{2}{c}{**Reference Extractant**} \\  & & & **Ethanol 40\%** & **Ethanol 70\%** & **MN40** & **MN70** \\ \hline \multicolumn{6}{c}{Staphylococci} \\ \hline _Staphylococcus aureus_ & ATCC 25923 & S & 13.00 \(\pm\) 0.54 & 18.10 \(\pm\) 1.50 & Growth & 22.17 \(\pm\) 1.15 * \\ \hline _Staphylococcus aureus_ & Pharynx & BSSA & Growth & 20.35 \(\pm\) 1.05 & 11.63 \(\pm\) 0.08 * & 32.02 \(\pm\) 1.60 * \\ \hline _Staphylococcus aureus_ & Skin & S & Growth & 16.68 \(\pm\) 0.49 & 10.32 \(\pm\) 0.60 * & 24.71 \(\pm\) 1.55 * \\ \hline _Staphylococcus aureus_ & Wound & BSSA, MLS & Growth & 22.06 \(\pm\) 0.82 & 12.59 \(\pm\) 0.57 * & 33.00 \(\pm\) 3.67 * \\ \hline _Staphylococcus aureus_ & Wound & MRSA & Growth & 16.62 \(\pm\) 0.94 & 10.57 \(\pm\) 0.50 * & 23.99 \(\pm\) 1.34 * \\ \hline _Staphylococcus epidermidis_ & Skin & MLS, Ind+ & Growth & 22.75 \(\pm\) 1.01 & Growth & 22.96 \(\pm\) 0.57 \\ \hline _Staphylococcus haemolyticus_ & Sputum & MRSH & Growth & 14.25 \(\pm\) 0.49 & Growth & 22.99 \(\pm\) 2.17 * \\ \hline \multicolumn{6}{c}{Enterococci} \\ \hline _Enterococcus faecalis_ & Urethra & Tet, FQin & Growth & 11.73 \(\pm\)0.43 & 11.92 \(\pm\) 0.64 * & 21.12 \(\pm\) 1.29 * \\ \hline _Enterococcus faecalis_ & Urethra & Tet, FQin & Growth & Growth & 13.99 \(\pm\) 1.33 * & 16.80 \(\pm\) 0.54 * \\ \hline \multicolumn{6}{c}{\(\beta\)-Haemolytic streptococci} \\ \hline _Streptococcus pyogenes_ (\(\beta\) Str A) & Pharynx & S & 14.60 \(\pm\) 2.28 & 16.39 \(\pm\) 0.82 & Growth & 14.73 \(\pm\) 2.08 \\ \hline _Streptococcus pyogenes_ (\(\beta\) Str A) & Pharynx & S & Growth & 10.43 \(\pm\) 0.42 & Growth & 13.45 \(\pm\) 1.30 * \\ \hline _Streptococcus dysgualciae_ (\(\beta\) Str G) & Pharynx & S & Growth & Growth & Growth & 12.18 \(\pm\) 1.17 * \\ \hline \multicolumn{6}{c}{\(\alpha\)-Haemolytic streptococci} \\ \hline _Streptococcus anginosus_ & Pharynx & \multicolumn{2}{c}{AMO, Tet, MLS} & 15.51 \(\pm\) 1.28 & 13.63 \(\pm\) 1.20 & Growth & 14.59 \(\pm\) 0.76 \\ \hline _Streptococcus gondii_ & Oral cavity & S & 11.53 \(\pm\) 0.98 & 13.04 \(\pm\) 0.21 & Growth & 13.07 \(\pm\) 0.67 \\ \hline _Streptococcus oralis_ & Oral cavity & S & Growth & 14.67 \(\pm\) 0.56 & 9.67 \(\pm\) 0.63 * & 20.44 \(\pm\) 1.07 * \\ \hline _Streptococcus angulinis_ & Oral cavity & S & Growth & 19.54 \(\pm\) 0.87 & Growth & 20.65 \(\pm\) 1.02 \\ \hline _Streptococcus pneumonia_ & Sputum & S & Growth & Growth & Growth & Growth \\ \hline _Streptococcus pneumonia_ & Sputum & \(\beta\)-Lac, Tet & Growth & Growth & Growth & 17.40 \(\pm\) 0.21 * \\ \hline \multicolumn{6}{c}{Enterobacteria} \\ \hline _Escherichia coli_ & Wound & S & Growth & 8.70 \(\pm\) 0.52 & Growth & Growth \\ \hline _Escherichia coli_ & Wound & S & Growth & Growth & Growth & 12.89 \(\pm\) 0.56 * \\ \hline _Escherichia coli_ & Wound & \multicolumn{2}{c}{AMO Tet, FQin} & Growth & Growth & Growth & 11.79 \(\pm\) 0.69 * \\ \hline _Escherichia coli hly+_ & Faecal sample & AMO, MLs & Growth & Growth & Growth & 13.20 \(\pm\) 0.95 * \\ \hline _Escherichia fergusuni_ & Faecal sample & ES\(\beta\)L & Growth & Growth & Growth & Growth \\ \hline _Providencia retlgeri_ & Urine sample & ES\(\beta\)L & Growth & Growth & Growth & Growth \\ \hline _Morganella morganii_ & Urine sample & ES\(\beta\)L & Growth & Growth & Growth & Growth \\ \hline \multicolumn{6}{c}{Non-fermenting bacteria} \\ \hline _Pseudomonas aureginosa_ & Wound & ES\(\beta\)L & Growth & Growth & Growth & Growth \\ \hline _Pseudomonas aureginosa_ & Pus from the wound & ES\(\beta\)L & Growth & Growth & Growth & Growth \\ \hline _Acinetobacter baumani_ & Sputum & ES\(\beta\)L & Growth & Growth & Growth & \(10.61\pm 1.03\) * \\ \hline \multicolumn{6}{c}{Bacillus subtilis} \\ \hline \hline \end{tabular}
\end{table}